Aloe_Vera: profile and news

UCB says EU, US approve intravenous Keppra Feb 3, 2006
...on Friday that European and United States regulators have approved the use of the biopharmaceutical group's intravenous form of its anti-epilepsy drug Keppra. ... - Reuters

UCB Receives EMEA Positive Opinion and FDA Approvable Letter for ... Feb 3, 2006
Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion to approve marketing authorisation of Keppra® (levetiracetam) Concentrate ... - DG News

FDA clears UCB anti-seizure injectable Feb 3, 2006
BRUSSELS, Feb. 3 (UPI) -- Belgian firm UCB said Friday its anti-seizure injectable Keppra is "approvable" for US sales. The company ... - United Press International

Brussels shares higher midmorning; UCB climbs on regulator ... Feb 3, 2006
...midmorning, with UCB up after the pharmaceutical group received positive responses from EU and US regulators on its anti-epilepsy drug Keppra, analysts said. ... - Forbes

FDA delays approval of UCB epilepsy drug Feb 6, 2006
FDA requesting more information before the regulators will approve the company's marketing application for an intravenous version of its epilepsy drug Keppra. ... - Pharmaceutical Business Review

Brussels shares close down; D'Ieteren leads on target price ... Feb 3, 2006
...opinion' and a letter of approval from the European Medicines Agency and US Food and Drug Administration (FDA) respectively on the marketing of Keppra as an ... - Forbes

Brussels shares close lower; Dexia, KBC losses weigh UPDATE Mar 2, 2006
...important product for UCB as it forms the cornerstone of its strategy to minimize the impact of the patent expiry of Zyrtec in December 2007 and Keppra in 2009 ... - Forbes

ING Says UCB IV Drug Sales News Expected Feb 3, 2006
1003 GMT [Dow Jones] Regulatory approval for UCB's (UCB.BT) Keppra in an intravenous form will help boost the drug's sales to EUR1B in 08 from EUR600M in 05 ... - New Ratings

UCB Drug's Widened Approval A Positive Feb 3, 2006
0831 GMT [Dow Jones]--UCB share could get a boost from the approval of the intravenous use its anti-epilepsy drug Keppra in both the US and Europe, says Delta ... - New Ratings

Keppra as adjunctive treatment in idiopathic generalised epilepsy ... Jan 21, 2006
...generalised epilepsy ( IGE ) having primary generalised tonic-clonic ( PGTC ) seizures became free from all types of seizures when Keppra ( Levetiracetam ) was ... - Xagena.it,

HUGIN NEWS/UCB Receives EMEA Positive Opinion and FDA Approvable ... Feb 2, 2006
Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion to approve marketing authorisation of Keppra® (levetiracetam) Concentrate ... - Frankfurter Allgemeine Zeitung,

HUGIN NEWS/Lonza Acquires the Bioproducts Manufacturing Division ... Jan 16, 2006
UCB key products are Keppra® (antiepileptic), Xyzal® and Zyrtec® (antiallergics), Nootropil® (cerebral function regulator), Tussionex® (antitussive) and ... - Frankfurter Allgemeine Zeitung,

McNicholas picks Mardi Gras luminaries Jan 20, 2006
Cecilia Pratt, a freshman at the University of Cincinnati, was one of 15 students across the country who received the Keppra Family Epilepsy Scholarship from ... - Cincinnati Enquirer,

Lonza Acquires the Bioproducts Manufacturing Division of UCB Jan 17, 2006
UCB key products are Keppra(R) (antiepileptic), Xyzal(R) and Zyrtec(R) (antiallergics), Nootropil(R) (cerebral function regulator), Tussionex(R) (antitussive ... - NPIcenter (press release),

Brussels shares decline midmorning; UCB positive after Keppra ... Dec 8, 2005
...yesterday's gains after a lower close on Wall Street, but with pharmaceuticals group UCB gaining after the an update on epilepsy drug Keppra, dealers said. ... - Forbes

New Data on the Use of Keppra(R) (levetiracetam) as Adjunctive ... Dec 6, 2005
...generalised epilepsy (IGE) having primary generalised tonic-clonic (PGTC) seizures became free from all types of seizures when Keppra® (levetiracetam) was ... - Market Wire (press release)

UCB To Benefit From Keppra Tests-Delta Lloyd Dec 7, 2005
0825 GMT [Dow Jones] UCB (UCB.BT) announced Tuesday that tests surrounding epilepsy drug Keppra showed that 24.1% of patients became free of seizures over a 20 ... - New Ratings

Cost of Newer Epilepsy Drugs Prove Worth in Cutting Overall Health ... Dec 8, 2005
...found when they compared total costs of caring for epileptic patients based on whether the patient was being treated with levetiracetam (Keppra) -- one of the ... - DG News

UCB offers positive update on epilepsy drug Dec 8, 2005
Brussels-based pharmaceuticals group UCB has presented an update on clinical trial results which illustrate the ability of its drug Keppra to reduce the amount ... - Pharmaceutical Business Review

Levetiracetam Appears Effective in Juvenile Myoclonic Epilepsy ... Dec 8, 2005
...from juvenile myoclonic epilepsy were either seizure-free or achieved a 50% reduction in seizures by taking the anti-epileptic agent levetiracetam (Keppra). ... - DG News

Ailing child faces new hurdles Dec 5, 2005
...has up to 40 seizures a day and is on a host of medications, including Valium and such anti-seizure medications as Depakote, Vigabratin, Keppra and Zonegran. ... - Berkshire Eagle,

HUGIN NEWS/Xyrem® is Launched in Germany for the Treatment of ... Dec 8, 2005
UCB key products are Keppra® (antiepileptic), Xyzal® and Zyrtec® (antiallergics), Nootropil® (cerebral function regulator), Tussionex® (antitussive) and ... - Frankfurter Allgemeine Zeitung,

Blue Diesel Honored at the 2005 RX Club Awards Dec 8, 2005
Communications, Inc., www.inchord.com, Blue Diesel's parent company, in the best consumer Web site category; * Interactive seizure diary for Keppra®, in the ... - PharmaLive.com (press release),

Brussels shares slightly higher on positive sentiment; D'Ieteren ... Dec 7, 2005
UCB SA was up 0.43 eur or 1.01 pct at 42.88 eur after it confirmed yesterday positive results for its Keppra drug while Omega Pharma NV was the only stock in ... - Forbes

Healthbeat:Epilepsy Drugs for Kids Nov 23, 2005
...has recently approved the use of three medications for children four and older: Topamax® (topiramate), Trileptal® (oxcarbazepine) and Keppra® (levetiracetam ... - WHOI,

Health Alert: Epilepsy drug Nov 16, 2005
...and in different ways. The approval of the drugs Topomax, Trileptal and Keppra for children add to the ways doctors can help them. - WIS,

Epilepsy Meds Nov 28, 2005
...in different ways. The approval of the drugs topomax, trileptal and keppra for children adds to the ways doctors can help them. - WOWT,

Plugged in Nov 14, 2005
...patient has been diagnosed. This past year, Blue Diesel developed Keppra.com for UCB Pharma’s epilepsy drug Keppra. The agency built ... - Med Ad News (subscription),

New Brivaracetam Status Positive For UCB Nov 9, 2005
...for the treatment of symptomatic myoclonus is positive news, says Bank Degroof, as the drug could have a broader range of indications than Keppra, and the ... - New Ratings

UCB Receives FDA Orphan Drug Designation for Brivaracetam for the ... Nov 8, 2005
Brivaracetam, a SV2A ligand that is differentiated from levetiracetam (Keppra(R)) by its mechanism of action profile(1) has shown a significant antiepileptic ... - PrimeZone (press release),

Two Senior Pharma Executives as New Members of UCB's Executive ... Nov 21, 2005
UCB key products are Keppra(r) (antiepileptic), Xyzal(r) and Zyrtec(r) (antiallergics), Nootropil(r) (cerebral function regulator), Tussionex(tm) (antitussive ... - PrimeZone (press release),

Curtain-raiser on living with seizures Nov 25, 2005
Bureau of Epilepsy and by UCB, one of the new international biopharmaceutical manufacturers that produced, among other products, Keppra (levetiracetam). ... - Australian,

UCB Receives FDA Orphan Drug Designation for Brivaracetam for the ... Nov 9, 2005
Brivaracetam, a SV2A ligand that is differentiated from levetiracetam (Keppra®) by its mechanism of action profile has shown a significant antiepileptic ... - Chemie.de (press release),